These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16614499)

  • 1. Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.
    Lee JY; Oh WS; Ko KS; Heo ST; Moon CS; Ki HK; Kiem S; Peck KR; Song JH
    J Korean Med Sci; 2006 Apr; 21(2):188-92. PubMed ID: 16614499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
    You I; Kariyama R; Zervos MJ; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):37-41. PubMed ID: 10744365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
    Kobayashi Y
    Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Appropriate use of anti-methicillin-resistant Staphylococcus aureus agents in a retrospective study].
    Nakamura Y; Yokoyama I; Hashimoto N; Hasegawa A; Nakasa H; Nakamura H; Watanabe M; Nomura F; Watanabe A; Igari H; Sato T; Nakazawa K; Ariyoshi N; Kitada M
    Yakugaku Zasshi; 2008 Jul; 128(7):1073-9. PubMed ID: 18591876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of factors in selecting anti-methicillin-resistant Staphylococcus aureus drugs by doctors].
    Hayashi H; Matsuzaki T; Saito A; Aoyama T; Matsumoto Y
    Yakugaku Zasshi; 2008 Jan; 128(1):81-7. PubMed ID: 18176058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
    Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
    Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure].
    Inaba Y; Hiramatsu K
    Nihon Rinsho; 1998 Oct; 56(10):2699-705. PubMed ID: 9796340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reliability of disc-diffusion susceptibility testing for arbekacin, vancomycin and teicoplanin against methicillin-resistant Staphylococcus aureus].
    Kouda M; Homma S; Udagawa I; Tamura K; Fukuhara J; Takeuchi M
    Jpn J Antibiot; 1999 Dec; 52(12):681-9. PubMed ID: 10695023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
    Akins RL; Rybak MJ
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1925-9. PubMed ID: 10858356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.
    Hiramatsu K; Hanaki H; Ino T; Yabuta K; Oguri T; Tenover FC
    J Antimicrob Chemother; 1997 Jul; 40(1):135-6. PubMed ID: 9249217
    [No Abstract]   [Full Text] [Related]  

  • 11. The usefulness of arbekacin compared to vancomycin.
    Hwang JH; Lee JH; Moon MK; Kim JS; Won KS; Lee CS
    Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1663-6. PubMed ID: 22124537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods.
    Hershberger E; Aeschlimann JR; Moldovan T; Rybak MJ
    Antimicrob Agents Chemother; 1999 Mar; 43(3):717-21. PubMed ID: 10049300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
    LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus.
    Watanabe T; Ohashi K; Matsui K; Kubota T
    J Antimicrob Chemother; 1997 Apr; 39(4):471-6. PubMed ID: 9145819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
    Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G
    J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus.
    Hwang JH; Lee JH; Hwang JH; Chung KM; Lee EJ; Yoon YJ; Moon MK; Kim JS; Won KS; Lee CS
    J Korean Med Sci; 2015 Jun; 30(6):688-93. PubMed ID: 26028918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of arbekacin against clinical isolates of methicillin-resistant Staphylococcus aureus in a hospital.
    Kawakami Y; Furuwatari C; Akahane T; Okimura Y; Furihata K; Katsuyama T; Matsumoto H
    J Antibiot (Tokyo); 1994 Apr; 47(4):507-9. PubMed ID: 8195054
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro combinations of five intravenous antibiotics with dalfopristin-quinupristin against Staphylococcus aureus in a 3-dimensional model.
    Duez JM; Adochitei A; Péchinot A; Siebor E; Sixt N; Neuwirth C
    J Chemother; 2008 Dec; 20(6):684-9. PubMed ID: 19129064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.